Sales decline 10.25% to Rs 789.29 crore
Net profit of Alembic Pharmaceuticals rose 1.44% to Rs 121.56 crore in the quarter ended September 2017 as against Rs 119.83 crore during the previous quarter ended September 2016. Sales declined 10.25% to Rs 789.29 crore in the quarter ended September 2017 as against Rs 879.42 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales789.29879.42 -10 OPM %22.7020.21 -PBDT186.47177.31 5 PBT160.82156.69 3 NP121.56119.83 1Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)